SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

InQpharm Europe to appeal white kidney bean-weight loss rejection

By Shane Starling , 16-Jul-2014
Last updated on 29-Jan-2015 at 13:04 GMT2015-01-29T13:04:53Z

InQpharm Europe to appeal white kidney bean-weight loss rejection

The CEO of InQpharm Europe says the firm will appeal against its health claim rejection for a white kidney bean extract and weight loss which EFSA rejected this week.

InQpharm Europe’s dossier under the EU nutrition and health claims regulation (NHCR) contained four human intervention trials but did not draw a positive verdict from the European Food Safety Authority’s (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA).

It said one study was, “at risk of bias.” Another “suffered from methodological limitations and that no evidence was provided for a mechanism by which the standardised aqueous extract from white kidney bean could exert the claimed effect.”

Peer review is not NDA review

InQpharm Europe CEO Thomas Hafner said his firm was disappointed not to be able to respond to the accusations of bias before the opinion went public.

We didnt get a chance to respond to this criticism, and feel there is no risk of bias because we followed the same procedures applied in drug studies throughout the world, he said.

We will provide EFSA with information on the conduct of the analysis to overcome these concerns. Furthermore, the study was published by the peer-reviewed, and highly respected journal Obesity, and at no time was this raised as a matter of possible concern.

He added: We were also a little surprised that EFSA questioned the mode of action of white kidney bean extract since there is solid evidence demonstrating that the ingredient inhibits alpha amylase, the enzyme that digests starch.

Inqpharm’s submission referred to a proprietary extract called PhaseLite developed by US firm Pharmachem Laboratories.

“…we are confident that we can overcome their objections with additional data, said Hafner.

The ingredient has GRAS status in the US and two permitted structure/function claims for starch reduction and weight loss.

Mitch Skop, senior director, new product development at Pharmachem, said: We fully support InQpharms efforts, and will provide all possible assistance during the appeal process.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars